Department of Colorectal Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China.
Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
EBioMedicine. 2021 Jul;69:103452. doi: 10.1016/j.ebiom.2021.103452. Epub 2021 Jun 26.
Intestinal obstruction caused by intestinal fibrosis is a common and serious complication of Crohn's disease (CD). Intestinal fibroblasts, the main effector cells mediating gastrointestinal fibrosis, are activated during chronic inflammation. However, the mechanism of fibroblast activation in CD has not been well elucidated.
Fibroblasts isolated from stenotic and nonstenotic intestines of CD patients were used for RNA sequencing. Immunohistochemical and immunofluorescent staining was performed to evaluate the correlation between intestinal fibrosis and YAP/TAZ expression in our CD cohort and a DSS-induced chronic colitis murine model. A Rho-associated coiled-coil-containing protein kinase 1 (ROCK1) inhibitor was used to explore the ROCK1-YAP/TAZ axis in intestinal fibroblasts in vitro and DSS-induced chronic colitis murine model in vivo.
The expression of YAP/TAZ was significantly upregulated in stenotic fibroblasts, which was associated with the YAP/TAZ target gene signature. YAP/TAZ knockdown suppressed the activation of intestinal fibroblasts. In intestinal fibroblasts, YAP/TAZ were activated by the Rho-ROCK1 signalling pathway. High YAP/TAZ expression was positively correlated with ROCK1 expression, which is a prognostic marker for intestinal obstruction in CD patients.
YAP/TAZ activation can lead to fibroblast activation and intestinal obstruction in CD. The effect of ROCK1 inhibitor on alleviating intestinal fibrosis is associated with YAP/TAZ inhibition. Targeted inhibition of YAP/TAZ in fibroblasts may be a potential therapeutic strategy to suppress intestinal fibrosis in CD.
This work was supported by the National Key R&D Program of China (2019YFC1316002), the NSFC (81873547, 82073201, 81874177, 82000481) and the Shanghai Sailing Program (20YF1429400).
由肠道纤维化引起的肠梗阻是克罗恩病(CD)的常见且严重的并发症。肠道成纤维细胞是介导胃肠道纤维化的主要效应细胞,在慢性炎症期间被激活。然而,CD 中成纤维细胞的激活机制尚未得到很好的阐明。
使用来自 CD 患者狭窄和非狭窄肠段的成纤维细胞进行 RNA 测序。进行免疫组织化学和免疫荧光染色,以评估我们的 CD 队列和 DSS 诱导的慢性结肠炎小鼠模型中肠道纤维化与 YAP/TAZ 表达之间的相关性。使用 Rho 相关卷曲螺旋蛋白激酶 1(ROCK1)抑制剂在体外研究肠成纤维细胞中的 ROCK1-YAP/TAZ 轴和 DSS 诱导的慢性结肠炎小鼠模型体内。
在狭窄的成纤维细胞中,YAP/TAZ 的表达明显上调,与 YAP/TAZ 靶基因特征相关。YAP/TAZ 敲低抑制了肠成纤维细胞的激活。在肠成纤维细胞中,YAP/TAZ 被 Rho-ROCK1 信号通路激活。高 YAP/TAZ 表达与 ROCK1 表达呈正相关,ROCK1 是 CD 患者肠梗阻的预后标志物。
YAP/TAZ 的激活可导致 CD 中的成纤维细胞激活和肠梗阻。ROCK1 抑制剂对缓解肠道纤维化的作用与 YAP/TAZ 抑制有关。靶向抑制成纤维细胞中的 YAP/TAZ 可能是抑制 CD 中肠道纤维化的潜在治疗策略。
本工作得到了国家重点研发计划(2019YFC1316002)、国家自然科学基金(81873547、82073201、81874177、82000481)和上海市扬帆计划(20YF1429400)的支持。